Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
San San MinVarun MehraJennifer ClayGemma F CrossAbdel DouiriTracy DewTanya N BasuVictoria PotterM Mansour CeesayAntonio PagliucaRoy A SherwoodRoyce P VincentPublished in: Journal of clinical pathology (2017)
This pilot data support the usefulness of these composite biomarker panels in the prediction of severity and diagnosis of aGVHD in patients undergoing T-cell-depleted reduced intensity allogeneic HSCT.
Keyphrases
- stem cell transplantation
- hematopoietic stem cell
- stem cells
- patients undergoing
- bone marrow
- liver failure
- high dose
- respiratory failure
- study protocol
- big data
- drug induced
- allogeneic hematopoietic stem cell transplantation
- clinical trial
- low dose
- mesenchymal stem cells
- cell therapy
- acute respiratory distress syndrome